866-997-4948(US-Canada Toll Free)

Bioreactors and Fermenters Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2016 - 2024

Published By :

Transparency

Published Date : May 2017

Category :

Biotechnology

No. of Pages : 182 Pages

Global Bioreactors and Fermenters Market: Overview

Bioreactors and fermenters are mainly used in research institutes and bioprocessing industries. Bioreactors are employed for the cultivation of mammalian, plants, and insect cells, and for large scale production of pharmaceuticals, antibodies, vaccines, etc., or for the bioconversion of organic wastes. Fermenters are utilized for the growth and maintenance of a population of bacterial or fungal cells in a controlled mode. They are small as compared to bioreactors. This report analyzes the current and future prospects of the bioreactors and fermenters market based on product, process, end user and geography.  

Global Bioreactors and Fermenters Market: Scope of the Report

The research is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the expected revenue of bioreactors used in biopharmaceutical industries, CROs, etc. in the near future. Primary research formed the bulk of our research efforts with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders. Secondary research involved study of company websites, annual reports, press releases, investor presentations, analyst presentation and various international and national databases. The report provides estimated market size in terms of US$ Mn for product, process, end user, and geography for the period 2015 to 2024. The revenue generated from product type was calculated by considering the adoption rate of bioreactors and fermenters across all geographies, number of product launched, average cost of products, trends in industry, and end user trends, among others.

Global Bioreactors and Fermenters Market: Segmentation

The market report comprises an elaborated executive summary, which includes market snapshot that provides information about various segments of the market. It also provides information and data analysis of the market with respect to market segments based on product, process, end user, and geography. The market overview section of the report analyzes market dynamics such as drivers, restraints and opportunities that influences the bioreactors and fermenters market in the current and future scenario. The report also provides value chain analysis of the market that describes the sequence of activities involved, from identification of the market need to their final reach to the end users. Furthermore, the report provides Porter’s five force analysis that studies five factors and their impact on the bioreactors and fermenters market.

Global Bioreactors and Fermenters Market: Competitive Analysis

Market share analysis among the market players is analyzed to signify the contribution of these players in the market in terms of percentage share. All these factors will help the market players to decide about the business strategies and plans to strengthen their positions in the global market. Based on geography, the market has been analyzed for major regions: North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. The study also covers detailed country analysis contributing majorly in the bioreactors and fermenters market.

The report also profiles the major players in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in the bioreactors and fermenters market include Applikon Biotechnology B.V., Danaher Corporation, Eppendorf AG, Finesse Solutions, Inc., GE Healthcare, Merck KGaA, PBS Biotech, Inc., PIERRE GUERIN TECHNOLOGIES, Sartorius AG, SOLARIS BIOTECHNOLOGY srl, Thermo Fisher Scientific Inc and ZETA Holding GmbH. Acquisitions was the primary strategy adopted by the major market players to enter into the bioreactors and fermenters market. For instance, GE Healthcare acquired Xcellerex, Inc. in 2012, to establish its footprints in single-use bioreactors market.

The Bioreactors and Fermenters Market has been segmented as follows:

Bioreactors and Fermenters Market, by Product, Revenue (US$ Mn) 2016-2024

  • Single-use Bioreactors
  • Multiple-use Bioreactors

Bioreactors and Fermenters Market, by Process, Revenue (US$ Mn) 2016-2024

  • Fed batch
  • Continuous
  • Batch

Bioreactors and Fermenters Market, by End User, Revenue (US$ Mn) 2016-2024

  • Biopharmaceutical companies
  • CROs
  • Academic & Research Institutes

Bioreactors and Fermenters Market, by Geography, Revenue (US$ Mn), 2016-2024

  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia Pacific
  • Middle East & Africa
  • U.A.E.
  • South Africa
  • Rest of Middle East & Africa

Table of Content

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Bioreactors and Fermenters Market

4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity
4.4. Global Bioreactors and Fermenters Market Analysis and Forecasts, 2016–2024
4.4.1. Market Volume Projections
4.5. Bioreactors and Fermenters Market - Global Supply Demand Scenario
4.6. Porter’s Five Force Analysis
4.7. Value Chain Analysis
4.7.1. List of active market participants 
4.8. Market Outlook

5. Global Bioreactors and Fermenters Market Analysis and Forecasts, By Product 
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Key Trends
5.4. Market Value Forecast By Product
5.4.1. Single-use bioreactors
5.4.2. Multi-use bioreactors
5.5. Market Attractiveness By Product 

6. Global Bioreactors and Fermenters Market Analysis and Forecasts, By Process 
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Key Trends
6.4. Market Value Forecast By Process
6.4.1. Fed batch
6.4.2. Continuous
6.4.3. Batch
6.5. Market Attractiveness By Process 

7. Global Bioreactors and Fermenters Market Analysis and Forecasts, By End-User 
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Key Trends
7.4. Market Value Forecast By End-User 
7.4.1. Biopharmaceutical companies
7.4.2. CROs
7.4.3. Academic & Research Institutes
7.5. Market Attractiveness By End-User 

8. Global Bioreactors and Fermenters Market Analysis and Forecasts, By Region
8.1. Key Findings
8.2. Market Value Forecast By Region
8.2.1. North America 
8.2.2. Europe 
8.2.3. Asia Pacific 
8.2.4. Latin America 
8.2.5. Middle East and Africa 
8.3. Market Attractiveness By Country/Region

9. North America Bioreactors and Fermenters Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.1.2. Key Trends
9.2. Market Value Forecast By Product 
9.2.1. Single-use bioreactors
9.2.2. Multi-use bioreactors
9.3. Market Value Forecast By Process 
9.3.1. Fed batch
9.3.2. Continuous
9.3.3. Batch
9.4. Market Value Forecast By End-User 
9.4.1. Biopharmaceutical companies
9.4.2. CROs
9.4.3. Academic & Research Institutes
9.5. Market Value Forecast By Country 
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis 

10. Europe Bioreactors and Fermenters Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.1.2. Key Trends
10.2. Market Value Forecast By Product 
10.2.1. Single-use bioreactors
10.2.2. Multi-use bioreactors
10.3. Market Value Forecast By Process 
10.3.1. Fed batch
10.3.2. Continuous
10.3.3. Batch
10.4. Market Value Forecast By End-User , 2014–2024
10.4.1. Biopharmaceutical companies
10.4.2. CROs
10.4.3. Academic & Research Institutes
10.5. Market Value Forecast By Country , 2014–2024
10.5.1. Germany 
10.5.2. France 
10.5.3. U.K. 
10.5.4. Rest of Europe
10.6. Market Attractiveness Analysis 

11. Asia Pacific Bioreactors and Fermenters Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.1.2. Key Trends
11.2. Market Value Forecast By Product 
11.2.1. Single-use bioreactors
11.2.2. Multi-use bioreactors
11.3. Market Value Forecast By Process 
11.3.1. Fed batch
11.3.2. Continuous
11.3.3. Batch
11.4. Market Value Forecast By End-User 
11.4.1. Biopharmaceutical companies
11.4.2. CROs
11.4.3. Academic & Research Institutes
11.5. Market Value Forecast By Country 
11.5.1. Japan 
11.5.2. China 
11.5.3. India 
11.5.4. Australia 
11.5.5. Rest of Asia Pacific
11.6. Market Attractiveness Analysis 

12. Latin America Bioreactors and Fermenters Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.1.2. Key Trends
12.2. Market Value Forecast By Product 
12.2.1. Single-use bioreactors
12.2.2. Multi-use bioreactors
12.3. Market Value Forecast By Process 
12.3.1. Fed batch
12.3.2. Continuous
12.3.3. Batch
12.4. Market Value Forecast By End-User 
12.4.1. Biopharmaceutical companies
12.4.2. CROs
12.4.3. Academic & Research Institutes
12.5. Market Value Forecast By Country 
12.5.1. Brazil 
12.5.2. Mexico 
12.5.3. Rest of Latin America
12.6. Market Attractiveness Analysis 

13. Middle East and Africa Bioreactors and Fermenters Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.1.2. Key Trends
13.2. Market Value Forecast By Product 
13.2.1. Single-use bioreactors
13.2.2. Multi-use bioreactors
13.3. Market Value Forecast By Process 
13.3.1. Fed batch
13.3.2. Continuous
13.3.3. Batch
13.4. Market Value Forecast By End-User 
13.4.1. Biopharmaceutical companies
13.4.2. CROs
13.4.3. Academic & Research Institutes
13.5. Market Value Forecast By Country 
13.5.1. Saudi Arabia 
13.5.2. South Africa 
13.5.3. Rest of MEA
13.6. Market Attractiveness Analysis 

14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of companies)
14.2. Market Share Analysis By Company (2015)
14.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
14.3.1. Applikon Biotechnology B.V. 
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Business Overview
14.3.1.3. Product Portfolio 
14.3.1.4. Financial Overview 
14.3.1.5. SWOT Analysis 
14.3.1.6. Strategic overview
14.3.2. Danaher Corporation
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Business Overview
14.3.2.3. Product Portfolio 
14.3.2.4. Financial Overview 
14.3.2.5. SWOT Analysis 
14.3.2.6. Strategic overview
14.3.3. Eppendorf AG
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Business Overview
14.3.3.3. Product Portfolio 
14.3.3.4. Financial Overview 
14.3.3.5. SWOT Analysis 
14.3.3.6. Strategic overview 
14.3.4. Finesse Solutions, Inc. 
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Business Overview
14.3.4.3. Product Portfolio 
14.3.4.4. Financial Overview 
14.3.4.5. SWOT Analysis 
14.3.4.6. Strategic overview
14.3.5. GE Healthcare
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Business Overview
14.3.5.3. Product Portfolio 
14.3.5.4. Financial Overview 
14.3.5.5. SWOT Analysis 
14.3.5.6. Strategic overview
14.3.6. Merck KGaA
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Business Overview
14.3.6.3. Product Portfolio 
14.3.6.4. Financial Overview 
14.3.6.5. SWOT Analysis 
14.3.6.6. Strategic overview 
14.3.7. PBS Biotech, Inc.
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Business Overview
14.3.7.3. Product Portfolio 
14.3.7.4. Financial Overview 
14.3.7.5. SWOT Analysis 
14.3.7.6. Strategic overview
14.3.8. PIERRE GUERIN TECHNOLOGIES
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Business Overview
14.3.8.3. Product Portfolio 
14.3.8.4. Financial Overview 
14.3.8.5. SWOT Analysis 
14.3.8.6. Strategic overview
14.3.9. Sartorius AG
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Business Overview
14.3.9.3. Product Portfolio 
14.3.9.4. Financial Overview 
14.3.9.5. SWOT Analysis 
14.3.9.6. Strategic overview
14.3.10. SOLARIS BIOTECHNOLOGY srl
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Business Overview
14.3.10.3. Product Portfolio 
14.3.10.4. Financial Overview 
14.3.10.5. SWOT Analysis 
14.3.10.6. Strategic overview
14.3.11. Thermo Fisher Scientific Inc
14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.11.2. Business Overview
14.3.11.3. Product Portfolio 
14.3.11.4. Financial Overview 
14.3.11.5. SWOT Analysis 
14.3.11.6. Strategic overview 
14.3.12. ZETA Holding GmbH
14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.12.2. Business Overview
14.3.12.3. Product Portfolio 
14.3.12.4. Financial Overview 
14.3.12.5. SWOT Analysis 
14.3.12.6. Strategic overview

List of Table

Table 01: Global Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Product Type, 2016–2024
Table 02: Global Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Process Type, 2016–2024
Table 03: Global Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by End user, 2016–2024
Table 04: Global Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Region, 2016–2024
Table 05: North America Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Product, 2016–2024
Table 06: North America Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Process, 2016–2024
Table 07: North America Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by End user, 2016–2024
Table 08: North America Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Country, 2016–2024
Table 09: Europe Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Product, 2016–2024
Table 10: Europe Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Process, 2016–2024
Table 11: Europe Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by End user, 2016–2024
Table 12: Europe Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Country, 2016–2024
Table 13: Asia Pacific Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Product, 2016–2024
Table 14: Asia Pacific Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Process, 2016–2024
Table 15: Asia Pacific Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by End user, 2016–2024
Table 16: Asia Pacific Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Country, 2016–2024
Table 17: Latin America Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Product, 2016–2024
Table 18: Latin America Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Process, 2016–2024
Table 19: Latin America Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by End user, 2016–2024
Table 20: Latin America Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Country, 2016–2024
Table 21: Middle East and Africa Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Product, 2016–2024
Table 22: Middle East and Africa Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Process, 2016–2024
Table 23: Middle East and Africa Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by End user, 2016–2024
Table 24: Middle East and Africa Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Country, 2016–2024

List of Chart

Figure 01: Global Bioreactors and Fermenters Market Size (US$ Mn) Forecast, 2016–2024
Figure 02: Global Bioreactors and Fermenters Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 03: Global Single-use Bioreactors Market Revenue (US$ Mn), 2015-2024
Figure 04: Global Multiple-use Bioreactors Market Revenue, US$ Mn, 2015–2024
Figure 05: Bioreactors and Fermenters Market Attractiveness Analysis By Product Type
Figure 06: Global Bioreactors and Fermenters Market Value Share Analysis By Process Type, 2016 and 2024
Figure 07: Fed batch Bioreactors Market Revenue, US$ Mn, 2014–2024
Figure 08: Global Continuous Process Bioreactors Market Revenue, US$ Mn, 2014–2024
Figure 09: Global Batch Process Bioreactors Market Revenue, US$ Mn, 2014–2024
Figure 10: Global Bioreactors and Fermenters Market Attractiveness Analysis, By Process Type
Figure 11: Global Bioreactors and Fermenters Market Value Share Analysis By End users, 2016 and 2024
Figure 12: Global Biopharmaceutical companies Market Revenue (US$ Mn), 2016–2024
Figure 13: Global CROs Market Revenue (US$ Mn), 2016–2024
Figure 14: Global Academic & Research Institutes Market Revenue (US$ Mn), 2016–2024
Figure 15: Bioreactors and Fermenters Market Attractiveness Analysis, by End user
Figure 16: Global Bioreactors and Fermenters Market Analysis By Region, 2016 and 2024
Figure 17: Global Bioreactors and Fermenters Market Attractiveness Analysis, By Region Type
Figure 18: North America Bioreactors and Fermenters  Market Size (US$ Mn) Forecast, 2016–2024
Figure 19: North America Market Attractiveness Analysis By Country
Figure 20: North America Bioreactors and Fermenters Market Value Share Analysis By Product Type, 2016 and 2024
Figure 21: North America Bioreactors and Fermenters Market Value Share Analysis By Process Type, 2016 and 2024
Figure 22: North America Bioreactors and Fermenters Market Value Share Analysis By End User Type, 2016 and 2024
Figure 23: North America Market Value Share Analysis By Country, 2016 and 2024
Figure 24: North America Market Attractiveness Analysis, by Product 
Figure 25: North America Market Attractiveness Analysis, by Process
Figure 26: North America Market Attractiveness Analysis, by End User
Figure 27: Europe Bioreactors and Fermenters Market Size (US$ Mn) Forecast, 2016–2024
Figure 28: Europe Market Attractiveness Analysis, by Country
Figure 29: Europe Market Value Share Analysis By Product Type, 2016 and 2024
Figure 30: Europe Market Value Share Analysis By Process Type, 2016 and 2024
Figure 31: Europe Bioreactors and Fermenters Market Value Share Analysis By End User Type, 2016 and 2024
Figure 32: Europe Market Value Share Analysis, by Country, 2016 and 2024
Figure 33: Europe Market Attractiveness Analysis, by Product
Figure 34: Europe Market Attractiveness Analysis, by Process
Figure 35: Europe Market Attractiveness Analysis, by End User
Figure 36: Asia Pacific Bioreactors and Fermenters Market Size (US$ Mn) Forecast, 2016–2024
Figure 37: Asia Pacific Market Attractiveness Analysis, by Country
Figure 38: Asia Pacific Market Value Share Analysis By Product Type, 2016 and 2024
Figure 39: Asia Pacific Market Value Share Analysis By Process Type, 2016 and 2024
Figure 40: Asia Pacific Bioreactors and Fermenters Market Value Share Analysis By End User Type, 2016 and 2024
Figure 41: Asia Pacific Market Value Share Analysis, by Country, 2016 and 2024
Figure 42: Asia Pacific Market Attractiveness Analysis, by Product 
Figure 43: Asia Pacific Market Attractiveness Analysis, by Process
Figure 44: Asia Pacific Market Attractiveness Analysis, by End User
Figure 45: Latin America Bioreactors and Fermenters Market Size (US$ Mn) Forecast, 2016–2024
Figure 46: Latin America Market Attractiveness Analysis, by Country
Figure 47: Latin America Market Value Share Analysis By Product Type, 2016 and 2024
Figure 48: Latin America Market Value Share Analysis By Process Type, 2016 and 2024
Figure 49: Latin America Bioreactors and Fermenters Market Value Share Analysis By End User Type, 2016 and 2024
Figure 50: Latin America Market Value Share Analysis, by Country, 2016 and 2024
Figure 51: Latin America Market Attractiveness Analysis, by Product 
Figure 52: Latin America Market Attractiveness Analysis, by Process
Figure 53: Latin America Market Attractiveness Analysis, by End User
Figure 54: Middle East and Africa Bioreactors and Fermenters Market Size (US$ Mn) Forecast, 2016–2024
Figure 55: Middle East and Africa Market Attractiveness Analysis, by Country
Figure 56: Middle East and Africa Market Value Share Analysis By Product Type, 2016 and 2024
Figure 57: Middle East and Africa Market Value Share Analysis By Process Type, 2016 and 2024
Figure 58: Middle East and Africa Bioreactors and Fermenters Market Value Share Analysis By End User Type, 2016 and 2024
Figure 59: Middle East and Africa Market Value Share Analysis, by Country, 2016 and 2024
Figure 60: Middle East and Africa Market Attractiveness Analysis, by Product 
Figure 61: Middle East and Africa Market Attractiveness Analysis, by Process
Figure 62: Middle East and Africa Market Attractiveness Analysis, by End User
Figure 63: Global Bioreactors and Fermenters Market Share Analysis By Company (2015)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *